Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Herrmann

Showing results (701-710 of 773) with videos related to

Pageof 78
Sort By:
The New England Journal of Medicine|March 27, 2012
Transcatheter aortic-valve replacement for inoperable severe aortic stenosisRaj R Makkar, Gregory P Fontana, Hasan Jilaihawi, et al.
Journal of the American College of Cardiology|July 12, 2014
Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trialLars G Svensson, Eugene H Blackstone, Jeevanantham Rajeswaran, et al.
Lancet (London, England)|March 20, 2015
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trialMichael J Mack, Martin B Leon, Craig R Smith, et al.
JAMA Cardiology|October 9, 2024
Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical TrialDidier Tchétché, Roxana Mehran, Daniel J Blackman, et al.
European Heart Journal. Cardiovascular Imaging|May 2, 2024
Left and right ventricular longitudinal systolic function following aortic valve replacement in the PARTNER 2 trial and registryIria Silva, Julien Ternacle, Rebecca T Hahn, et al.
JACC. Cardiovascular Interventions|July 12, 2023
First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR SystemSyed Zaid, Guilherme F Attizzani, Parasuram Krishnamoorthy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 30, 2022
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trialTaishi Okuno, George D Dangas, Christian Hengstenberg, et al.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
The Annals of Thoracic Surgery|December 18, 2024
Five- Year Outcomes in Low-Risk Patients Undergoing Surgery in the PARTNER 3 TrialVinod H Thourani, Martin B Leon, Raj Makkar, et al.
Journal of the American Heart Association|March 18, 2026
Simple Index for Identifying Patients at Increased Risk of Suboptimal Forward-Flow Hemodynamics After Transcatheter Aortic Valve ReplacementPier Pasquale Leone, Damiano Regazzoli, Matteo Sturla, et al.
Pageof 78

Showing results (701-710 of 773) with videos related to

Sort By:
Pageof 78
The New England Journal of Medicine|March 27, 2012
Transcatheter aortic-valve replacement for inoperable severe aortic stenosisRaj R Makkar, Gregory P Fontana, Hasan Jilaihawi, et al.
Journal of the American College of Cardiology|July 12, 2014
Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trialLars G Svensson, Eugene H Blackstone, Jeevanantham Rajeswaran, et al.
Lancet (London, England)|March 20, 2015
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trialMichael J Mack, Martin B Leon, Craig R Smith, et al.
JAMA Cardiology|October 9, 2024
Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical TrialDidier Tchétché, Roxana Mehran, Daniel J Blackman, et al.
European Heart Journal. Cardiovascular Imaging|May 2, 2024
Left and right ventricular longitudinal systolic function following aortic valve replacement in the PARTNER 2 trial and registryIria Silva, Julien Ternacle, Rebecca T Hahn, et al.
JACC. Cardiovascular Interventions|July 12, 2023
First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR SystemSyed Zaid, Guilherme F Attizzani, Parasuram Krishnamoorthy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 30, 2022
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trialTaishi Okuno, George D Dangas, Christian Hengstenberg, et al.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
The Annals of Thoracic Surgery|December 18, 2024
Five- Year Outcomes in Low-Risk Patients Undergoing Surgery in the PARTNER 3 TrialVinod H Thourani, Martin B Leon, Raj Makkar, et al.
Journal of the American Heart Association|March 18, 2026
Simple Index for Identifying Patients at Increased Risk of Suboptimal Forward-Flow Hemodynamics After Transcatheter Aortic Valve ReplacementPier Pasquale Leone, Damiano Regazzoli, Matteo Sturla, et al.
Pageof 78